Gauss

Recombinant Mouse CCL3 (MIP-1 Alpha) (carrier-free) 10 µg

Réf. UGAP : 3689593 Réf. Fournisseur : 593802 Réf. Constructeur : 593802
Recombinant Mouse CCL3 (MIP-1 Alpha) (carrier-free) 10 µg
Recombinant Mouse CCL3 (MIP-1 Alpha) (carrier-free) 10 µg
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

CCL3 is a chemokine belonging to the CC chemokine family. CCL3 is involved in activation and recruitment of lymphocytes, monocytes, and granulocytes during acute inflammation. In addition to regulating leukocyte migration, CCL3 enhances IFN-γ secretion from activated T cells and thus induces Th1 response. Moreover, CCL3 has been reported to be involved in susceptibility of HIV infection and disease progression of AIDS. Also, CCL3 expression is increased during atherosclerotic lesion formation in mice, and CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Previous data has shown that CCL3 uses CCR1 to promote neutrophil recruitment in OVA-challenged, immunized mice.;

En savoir plus

Garantie

Garantie 0 Mois

Description

CCL3 is a chemokine belonging to the CC chemokine family. CCL3 is involved in activation and recruitment of lymphocytes, monocytes, and granulocytes during acute inflammation. In addition to regulating leukocyte migration, CCL3 enhances IFN-γ secretion from activated T cells and thus induces Th1 response. Moreover, CCL3 has been reported to be involved in susceptibility of HIV infection and disease progression of AIDS. Also, CCL3 expression is increased during atherosclerotic lesion formation in mice, and CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Previous data has shown that CCL3 uses CCR1 to promote neutrophil recruitment in OVA-challenged, immunized mice.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
593802
Référence distributeur
593802
Vendu par
10 μg
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
Recombinant Protein
Certification
RUO
Type d’application
bioassay
Type de produit
Recombinant Protein
Température de conservation (°C)
-20 ou -70 °C
Température de transport
Blue Ice
Organisme cible
Mouse
Source biologique
E. coli
Seuil de coupure des masses moléculaires MWCO
The 69 amino acid recombinant protein has a predicted molecular mass of approximately 7.8 kD. The DTT-reduced protein migrates at approximately 12 kD and non-reduced protein migrates at approximately 14 kD by SDS-PAGE. Da
Concentration
10-25 µg sizes are bottled at 200 µg/mL.
Pureté
>97%, as determined by Coomassie stained SDS-PAGE. %
Matière dangereuse
Non
Code douanier
38220000
Classement NCBI
20302
Nomenclature Nacres
NA.77
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA77
Nomenclature CNRS
NA77
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Reprise en cas d’erreur client
non